Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 4

1(25.0%)

Phase 2

1(25.0%)

4Total

N/A(2)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06708065Not ApplicableCompleted

Effects of Armeo Power Robot Therapy on Upper Limb Recovery in Hemiplegic Stroke Patients

Role: collaborator

NCT05203744Phase 4Unknown

Escalating Monthly Doses of Tafenoquine in Healthy Volunteers

Role: collaborator

NCT05173402Completed

Treating Gnathic Form of Mesial Occlusion in Early Adolescence Patients

Role: lead

NCT03093129Phase 2Unknown

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer (NeoART-V)

Role: lead

NCT01018381Not ApplicableCompleted

Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection

Role: lead

All 5 trials loaded